Abstract
Population-based studies of children presenting with dry night cough alone compared with those who also wheeze are few and inconclusive.
Luftibus in the school is a population-based study of schoolchildren conducted between 2013–2016 in Zurich, Switzerland. We divided children into four mutually exclusive groups based on reported dry night cough (‘cough’) and wheeze and compared parent-reported symptoms, comorbidities and exposures using multinomial regression, FeNO using quantile regression, spirometry using linear regression and healthcare use and treatments using descriptive statistics.
Among 3457 schoolchildren aged 6–17 years, 294 (9%) reported ‘cough’, 181 (5%) reported ‘wheeze’, 100 (3%) reported ‘wheeze and cough’ and 2882 (83%) were ‘asymptomatic.’ Adjusting for confounders in a multinomial regression, children with ‘cough’ reported more frequent colds, rhinitis and snoring than ‘asymptomatic’ children; children with ‘wheeze’ or ‘wheeze and cough’ more often reported hay fever, eczema and parental histories of asthma. FeNO and spirometry were similar among ‘asymptomatic’ and children with ‘cough,’ while children with ‘wheeze’ or ‘wheeze and cough’ had higher FeNO and evidence of bronchial obstruction. Children with ‘cough’ used healthcare less often than those with ‘wheeze,’ and they attended mainly primary care. Twenty-two children (7% of those with ‘cough’) reported a physician diagnosis of asthma and used inhalers. These had similar characteristics as children with wheeze.
Our representative population-based study suggests only a small subgroup (7%) of schoolchildren reporting dry night cough without wheeze have features typical of asthma, yet the majority (93%) should be investigated for alternative aetiologies, particularly upper airway disease.
Take home message Our population-based study found children with night cough alone clearly differ from those with wheeze, suggesting different aetiologies and pathophysiology. Yet, a small subgroup (7%) has features of asthma and may benefit from specific work-up.
Competing Interest Statement
Mallet MC, Mozun R, Ardura-Garcia C, Pedersen ESL, Jurca M, Kuehni CE have nothing to disclose. Latzin P reports personal fees from OM pharma, Polyphor, Santhera, Vertex, Vifor, Sanofi Aventis and grants from Vertex-all outside the submitted work. Moeller A reports personal fees from Vertex outside the submitted work.
Funding Statement
Lunge Zürich, Switzerland funded data collection and the Swiss National Science Foundation (SNF Grant: 320030_182628) funded our analysis.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the canton of Zurich approved the study (KEK-ZH-Nr (Kantonalen Ethikkommission Zürich): 2014-0491)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The anonymised dataset used for this study is available from the corresponding author upon reasonable request and if the study group members consent.